Multiple myeloma: open trials in Romania

• NCT05519085

  A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

  Trial Treatment · Phase 3 · Celgene

  Bucharest · Cluj-Napoca · Iași

  Registry updated 2026-10-30

• NCT06615479

  A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)

  Trial Treatment · Phase 3 · Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

  Institutul Clinic Fundeni, Bucharest · Spitalul Universitar de Urgență București, Bucharest · Institutul Regional de Oncologie Iasi, Iași

  Registry updated 2026-10-29

• NCT06980480

  A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma

  Trial Treatment · Phase 3 · Takeda

  Spitalul Clinic Colentina Bucuresti, Bucharest · Institutul Clinic Fundeni, Bucharest · Spitalul Clinic Colțea, Bucharest · Institute Of Oncology Prof. Dr. Ion Chiricuta Cluj-Napoca, Cluj-Napoca · Spitalul Clinic Municipal Filantropia Craiova, Craiova

  Registry updated 2026-10-13

• NCT05645107

  A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma

  Trial Treatment · Phase 3 · Grifols Therapeutics LLC

  Onco Card S.R.L., Brasov · Spitalul Clinic Colentina Bucuresti, Bucharest · Spitalul Universitar de Urgență București, Bucharest · Institutul Clinic Fundeni, Bucharest · Spitalul Clinic Colțea, Bucharest · Institute Of Oncology Prof. Dr. Ion Chiricuta Cluj-Napoca, Cluj-Napoca · Institutul Regional de Oncologie Iasi, Iași · Ovidius Clinical Hospital S.R.L, Ovidiu · Spitalul Clinic Municipal De Urgenta Timisoara, Timisoara

  Registry updated 2026-09-30

• NCT04879043

  Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma

  Trial Treatment · Phase 1/2 · Heidelberg Pharma AG

  Arensia Clinics S.R.L., Bucharest · Institute Of Oncology Prof. Dr. Ion Chiricuta Cluj-Napoca, Cluj-Napoca

  Registry updated 2026-09-17

• NCT05879757

  Real-world Usage of HyQvia in Multiple Myeloma Adults With Secondary Immunodeficiency

  Research · Takeda

  Spitalul Clinic Colentina, Bucharest · Institutul Clinic Fundeni, Bucharest · Institutul Oncologic Prof Dr Ion Chiricuta Cluj-Napoca, Cluj-Napoca · Spitalul Clinic Municipal Filantropia Craiova, Craiova

  Registry updated 2026-02-18

All Multiple myeloma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error